TP53 and acute promyelocytic leukemia: Furthermore, in acute promyelocytic leukemia (APL) cells, silencing NR4A1 can activate glycolytic transporter GLUT1 and decrease the expression of TIGAR (TP53-induced glycolysis and apoptosis regulator) to induce APL development (50).